Professor Kang Geon-wook of Seoul National University Hospital Appointed as the 11th President of the Korean Society of Nuclear Medicine

Professor Kang Geon-wook, Department of Nuclear Medicine, Seoul National University Hospital.

[Asia Economy Reporter Kim Young-won] Seoul National University Hospital announced on the 14th that Professor Kang Geon-wook of the Department of Nuclear Medicine has been inaugurated as the 11th president of the Korean Society of Nuclear Medicine.

Professor Kang was inaugurated as the new president at the 61st Korean Society of Nuclear Medicine Autumn Scientific Conference held on the 4th. His term is two years, starting from November 2022.

The Korean Society of Nuclear Medicine is an academic organization established in 1961 with the purpose of expanding academic research and facilitating communication among members to advance the field of nuclear medicine in Korea. To achieve these goals, it promotes activities such as hosting academic conferences, publishing journals and books, conducting research related to academic promotion and health improvement, and training specialists.

Professor Kang stated, "We will lead the expansion of the nuclear medicine field, spearheaded by 'Theranostics,' known as radiation missile therapy. To broaden the scope of clinical practice, we will establish clinical evidence and achieve mutual cooperation with the nuclear medicine industry to internationally lead the development of nuclear medicine."

Meanwhile, Professor Kang has served as the Deputy Director of the Seoul National University Institute of Biotechnology, Director of the Radiation Medicine Research Institute at Seoul National University Medical Research Institute, and Director of the Translational Medicine Research Institute at Seoul National University Hospital Biomedical Research Institute. He also holds positions such as Vice President and Chair of the Future Planning Committee of the Korean Radiation Protection Association, Chair of the Medical Committee of the World Council on Isotopes (WCI), Director of the World Molecular Imaging Society (WMIS), and Chair of the Asian Regional Cooperative Council for Nuclear Medicine (ARCCNM).

This content was produced with the assistance of AI translation services.